Short- and Long-Term Outcomes for Extremely Preterm Infants

 

 Buy Article Permissions and Reprints

Abstract

Prematurity is the leading cause of infant mortality worldwide. In developed countries, extremely preterm infants contribute disproportionately to both neonatal and infant mortality. Survival of this high-risk population has incrementally improved in recent years. Despite these improvements, approximately one in four extremely preterm infants dies during the birth hospitalization. Among those who survive, respiratory and other morbidities are common, although their effect on quality of life is variable. In addition, long-term neurodevelopmental impairment is a large concern for patients, clinicians, and families. However, the interplay of multiple factors contributes to neurodevelopmental impairment, with measures that change over time and outcomes that can be difficult to define and predict. Understanding outcomes of extremely preterm infants can help better counsel families regarding antenatal and postnatal care and guide strategies to improve survival without morbidity. This review summarizes recent evidence to provide an overview into the short- and long-term outcomes for extremely preterm infants.

Note

This review was supported, in part, by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers KL2TR000455 and UL1TR000454. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.

• References

• 1 Blencowe H, Cousens S, Oestergaard MZ , et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012; 379 (9832) 2162-2172
  CrossrefPubMedGoogle Scholar
• 2 Martin JA, Hamilton BE, Osterman MJK. Births: final data for 2013. In: National Vital Statistics Reports. Vol 64. no 1. Hyattsville, MD: National Center for Health Statistics; 2015
  Google Scholar
• 3 Mathews TJ, MacDorman MF, Thoma ME. Infant mortality statistics from the 2013 period linked birth/infant death data set. In: National Vital Statistics Reports. Vol 64 no 9. Hyattsville, MD: National Center for Health Statistics; 2015
  Google Scholar
• 4 Stoll BJ, Hansen NI, Bell EF , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015; 314 (10) 1039-1051
  CrossrefPubMedGoogle Scholar
• 5 Patel RM, Kandefer S, Walsh MC , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med 2015; 372 (4) 331-340
  CrossrefPubMedGoogle Scholar
• 6 Horbar JD, Carpenter JH, Badger GJ , et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 2012; 129 (6) 1019-1026
  CrossrefPubMedGoogle Scholar
• 7 Ancel PY, Goffinet F, Kuhn P , et al; EPIPAGE-2 Writing Group. Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study. JAMA Pediatr 2015; 169 (3) 230-238
  CrossrefPubMedGoogle Scholar
• 8 Shah PS, Sankaran K, Aziz K , et al; Canadian Neonatal Network. Outcomes of preterm infants <29 weeks gestation over 10-year period in Canada: a cause for concern?. J Perinatol 2012; 32 (2) 132-138
  CrossrefPubMedGoogle Scholar
• 9 Kusuda S, Fujimura M, Uchiyama A, Totsu S, Matsunami K ; Neonatal Research Network, Japan. Trends in morbidity and mortality among very-low-birth-weight infants from 2003 to 2008 in Japan. Pediatr Res 2012; 72 (5) 531-538
  CrossrefPubMedGoogle Scholar
• 10 Ishii N, Kono Y, Yonemoto N, Kusuda S, Fujimura M ; Neonatal Research Network, Japan. Outcomes of infants born at 22 and 23 weeks' gestation. Pediatrics 2013; 132 (1) 62-71
  CrossrefPubMedGoogle Scholar
• 11 Su BH, Hsieh WS, Hsu CH, Chang JH, Lien R, Lin CH ; Premature Baby Foundation of Taiwan (PBFT). Neonatal outcomes of extremely preterm infants from taiwan: comparison with Canada, Japan, and the USA. Pediatr Neonatol 2015; 56 (1) 46-52
  Google Scholar
• 12 Costeloe KL, Hennessy EM, Haider S, Stacey F, Marlow N, Draper ES. Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ 2012; 345: e7976
  CrossrefPubMedGoogle Scholar
• 13 Fellman V, Hellström-Westas L, Norman M , et al; EXPRESS Group. One-year survival of extremely preterm infants after active perinatal care in Sweden. JAMA 2009; 301 (21) 2225-2233
  CrossrefPubMedGoogle Scholar
• 14 Agarwal P, Sriram B, Rajadurai VS. Neonatal outcome of extremely preterm Asian infants ⩽28 weeks over a decade in the new millennium. J Perinatol 2015; 35 (4) 297-303
  CrossrefPubMedGoogle Scholar
• 15 Guillen U, DeMauro S, Ma L , et al. Survival rates in extremely low birthweight infants depend on the denominator: avoiding potential for bias by specifying denominators. Am J Obstet Gynecol 2011; 205 (4) 329.e1-329.e7
  CrossrefPubMedGoogle Scholar
• 16 Shah PS, Lee SK, Lui K , et al; International Network for Evaluating Outcomes of Neonates (iNeo). The International Network for Evaluating Outcomes of very low birth weight, very preterm neonates (iNeo): a protocol for collaborative comparisons of international health services for quality improvement in neonatal care. BMC Pediatr 2014; 14: 110
  CrossrefPubMedGoogle Scholar
• 17 Rysavy MA, Li L, Bell EF , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Between-hospital variation in treatment and outcomes in extremely preterm infants. N Engl J Med 2015; 372 (19) 1801-1811
  CrossrefPubMedGoogle Scholar
• 18 Ecker JL, Kaimal A, Mercer BM , et al; American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine. #3: Periviable birth. Am J Obstet Gynecol 2015; 213 (5) 604-614
  CrossrefPubMedGoogle Scholar
• 19 Ward Platt M. The MBRRACE-UK perinatal surveillance report. Arch Dis Child Fetal Neonatal Ed 2016; Jan; 101 (1) 4-5
  CrossrefPubMedGoogle Scholar
• 20 Ahle M, Drott P, Andersson RE. Epidemiology and trends of necrotizing enterocolitis in Sweden: 1987-2009. Pediatrics 2013; 132 (2) e443-e451
  CrossrefPubMedGoogle Scholar
• 21 Berrington JE, Hearn RI, Bythell M, Wright C, Embleton ND. Deaths in preterm infants: changing pathology over 2 decades. J Pediatr 2012; 160 (1) 49-53.e1
  CrossrefPubMedGoogle Scholar
• 22 Jacob J, Kamitsuka M, Clark RH, Kelleher AS, Spitzer AR. Etiologies of NICU deaths. Pediatrics 2015; 135 (1) e59-e65
  CrossrefPubMedGoogle Scholar
• 23 Schmidt B, Roberts RS, Davis PG , et al; Caffeine for Apnea of Prematurity (CAP) Trial Investigators; Caffeine for Apnea of Prematurity CAP Trial Investigators. Prediction of late death or disability at age 5 years using a count of 3 neonatal morbidities in very low birth weight infants. J Pediatr 2015; 167 (5) 982-986.e2
  CrossrefPubMedGoogle Scholar
• 24 Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child 1959; 97 (5, Pt 1): 517-523
  PubMedGoogle Scholar
• 25 Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980; 1 (8159) 55-59
  PubMedGoogle Scholar
• 26 Stoll BJ, Hansen NI, Bell EF , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010; 126 (3) 443-456
  CrossrefPubMedGoogle Scholar
• 27 Polin RA, Carlo WA ; Committee on Fetus and Newborn; American Academy of Pediatrics. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics 2014; 133 (1) 156-163
  CrossrefPubMedGoogle Scholar
• 28 Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2012; 11: CD001456
  PubMedGoogle Scholar
• 29 Stevens TP, Finer NN, Carlo WA , et al; SUPPORT Study Group of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). J Pediatr 2014; 165 (2) 240-249.e4
  CrossrefPubMedGoogle Scholar
• 30 Wyllie J, Perlman JM, Kattwinkel J , et al; Neonatal Resuscitation Chapter Collaborators. Part 7: Neonatal resuscitation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation 2015; 95: e169-e201
  CrossrefPubMedGoogle Scholar
• 31 Northway Jr WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276 (7) 357-368
  CrossrefPubMedGoogle Scholar
• 32 Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007; 357 (19) 1946-1955
  CrossrefPubMedGoogle Scholar
• 33 Northway Jr WH, Moss RB, Carlisle KB , et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990; 323 (26) 1793-1799
  Google Scholar
• 34 Schmidt B, Roberts RS, Davis P , et al; Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. N Engl J Med 2006; 354 (20) 2112-2121
  CrossrefPubMedGoogle Scholar
• 35 Schmidt B, Anderson PJ, Doyle LW , et al; Caffeine for Apnea of Prematurity (CAP) Trial Investigators. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 2012; 307 (3) 275-282
  CrossrefPubMedGoogle Scholar
• 36 Tyson JE, Wright LL, Oh W , et al; National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely-low-birth-weight infants. N Engl J Med 1999; 340 (25) 1962-1968
  CrossrefPubMedGoogle Scholar
• 37 Doyle LW, Ehrenkranz RA, Halliday HL. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2014; 5: CD001145
  PubMedGoogle Scholar
• 38 Committee on Fetus and Newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109 (2) 330-338
  CrossrefPubMedGoogle Scholar
• 39 Bassler D, Plavka R, Shinwell ES , et al; NEUROSIS Trial Group. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. N Engl J Med 2015; 373 (16) 1497-1506
  CrossrefPubMedGoogle Scholar
• 40 Patel RM, Leong T, Carlton DP, Vyas-Read S. Early caffeine therapy and clinical outcomes in extremely preterm infants. J Perinatol 2013; 33 (2) 134-140
  CrossrefPubMedGoogle Scholar
• 41 Dobson NR, Patel RM, Smith PB , et al. Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants. J Pediatr 2014; 164 (5) 992-998.e3
  CrossrefPubMedGoogle Scholar
• 42 Lodha A, Seshia M, McMillan DD , et al; Canadian Neonatal Network. Association of early caffeine administration and neonatal outcomes in very preterm neonates. JAMA Pediatr 2015; 169 (1) 33-38
  CrossrefPubMedGoogle Scholar
• 43 Dykes FD, Lazzara A, Ahmann P, Blumenstein B, Schwartz J, Brann AW. Intraventricular hemorrhage: a prospective evaluation of etiopathogenesis. Pediatrics 1980; 66 (1) 42-49
  PubMedGoogle Scholar
• 44 Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996; 75 (3) F183-F186
  CrossrefPubMedGoogle Scholar
• 45 Schena F, Francescato G, Cappelleri A , et al. Association between hemodynamically significant patent ductus arteriosus and bronchopulmonary dysplasia. J Pediatr 2015; 166 (6) 1488-1492
  CrossrefPubMedGoogle Scholar
• 46 Dudell GG, Gersony WM. Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr 1984; 104 (6) 915-920
  CrossrefPubMedGoogle Scholar
• 47 Noori S, McCoy M, Friedlich P , et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009; 123 (1) e138-e144
  CrossrefPubMedGoogle Scholar
• 48 Rozé JC, Cambonie G, Marchand-Martin L , et al; Hemodynamic EPIPAGE 2 Study Group. Association between early screening for patent ductus arteriosus and in-hospital mortality among extremely preterm infants. JAMA 2015; 313 (24) 2441-2448
  Google Scholar
• 49 Mirea L, Sankaran K, Seshia M , et al; Canadian Neonatal Network. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr 2012; 161 (4) 689-94.e1
  CrossrefPubMedGoogle Scholar
• 50 Schmidt B, Davis P, Moddemann D , et al; Trial of Indomethacin Prophylaxis in Preterms Investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344 (26) 1966-1972
  CrossrefPubMedGoogle Scholar
• 51 Bose CL, Laughon MM. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 2007; 92 (6) F498-F502
  CrossrefPubMedGoogle Scholar
• 52 Stoll BJ, Hansen N, Fanaroff AA , et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110 (2, Pt 1) 285-291
  CrossrefPubMedGoogle Scholar
• 53 Stoll BJ, Hansen NI, Sánchez PJ , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011; 127 (5) 817-826
  CrossrefPubMedGoogle Scholar
• 54 Stoll BJ, Hansen NI, Adams-Chapman I , et al; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292 (19) 2357-2365
  CrossrefPubMedGoogle Scholar
• 55 Adams-Chapman I, Bann CM, Das A , et al; Eunice Kennedy Shriver National Institutes of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J Pediatr 2013; 163 (4) 961-7.e3
  CrossrefPubMedGoogle Scholar
• 56 Benjamin Jr DK, Hudak ML, Duara S , et al; Fluconazole Prophylaxis Study Team. Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial. JAMA 2014; 311 (17) 1742-1749
  CrossrefPubMedGoogle Scholar
• 57 Aliaga S, Clark RH, Laughon M , et al. Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics 2014; 133 (2) 236-242
  CrossrefPubMedGoogle Scholar
• 58 Fitzgibbons SC, Ching Y, Yu D , et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 2009; 44 (6) 1072-1075 , discussion 1075–1076
  CrossrefPubMedGoogle Scholar
• 59 Hintz SR, Kendrick DE, Stoll BJ , et al; NICHD Neonatal Research Network. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005; 115 (3) 696-703
  CrossrefPubMedGoogle Scholar
• 60 Grave GD, Nelson SA, Walker WA , et al. New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning workshop. Pediatr Res 2007; 62 (4) 510-514
  CrossrefPubMedGoogle Scholar
• 61 Patel RM, Denning PW. Intestinal microbiota and its relationship with necrotizing enterocolitis. Pediatr Res 2015; 78 (3) 232-238
  CrossrefPubMedGoogle Scholar
• 62 Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990; 336 (8730) 1519-1523
  Google Scholar
• 63 Cristofalo EA, Schanler RJ, Blanco CL , et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr 2013; 163 (6) 1592-1595.e1
  Google Scholar
• 64 AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014; 4: CD005496
  PubMedGoogle Scholar
• 65 Terrin G, Passariello A, De Curtis M , et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics 2012; 129 (1) e40-e45
  CrossrefPubMedGoogle Scholar
• 66 Kuppala VS, Meinzen-Derr J, Morrow AL, Schibler KR. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 2011; 159 (5) 720-725
  CrossrefPubMedGoogle Scholar
• 67 Cotten CM, Taylor S, Stoll B , et al; NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009; 123 (1) 58-66
  CrossrefPubMedGoogle Scholar
• 68 Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis 2007; 10 (2) 133-140
  CrossrefPubMedGoogle Scholar
• 69 Stenson BJ, Tarnow-Mordi WO, Darlow BA , et al; BOOST II United Kingdom Collaborative Group; BOOST II Australia Collaborative Group; BOOST II New Zealand Collaborative Group. Oxygen saturation and outcomes in preterm infants. N Engl J Med 2013; 368 (22) 2094-2104
  CrossrefPubMedGoogle Scholar
• 70 Carlo WA, Finer NN, Walsh MC , et al; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010; 362 (21) 1959-1969
  CrossrefPubMedGoogle Scholar
• 71 Manley BJ, Kuschel CA, Elder JE, Doyle LW, Davis PG. Higher rates of retinopathy of prematurity after increasing oxygen saturation targets for very preterm infants: experience in a single center. J Pediatr 2015; (e-pub ahead of print). doi:10.1016/j.jpeds.2015.10.005
  PubMedGoogle Scholar
• 72 Mintz-Hittner HA, Kennedy KA, Chuang AZ ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011; 364 (7) 603-615
  CrossrefPubMedGoogle Scholar
• 73 Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000; 105 (2) 295-310
  Google Scholar
• 74 L. Orton J, McGinley JL, Fox LM, Spittle AJ. Challenges of neurodevelopmental follow-up for extremely preterm infants at two years. Early Hum Dev 2015; 91 (12) 689-694
  CrossrefPubMedGoogle Scholar
• 75 Vohr BR, Stephens BE, Higgins RD , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Are outcomes of extremely preterm infants improving? Impact of Bayley assessment on outcomes. J Pediatr 2012; 161 (2) 222-8.e3
  CrossrefPubMedGoogle Scholar
• 76 Schlapbach LJ, Adams M, Proietti E , et al; Swiss Neonatal Network & Follow-up Group. Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008. BMC Pediatr 2012; 12: 198
  CrossrefPubMedGoogle Scholar
• 77 Moore T, Hennessy EM, Myles J , et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ 2012; 345: e7961
  CrossrefPubMedGoogle Scholar
• 78 Anderson PJ, De Luca CR, Hutchinson E, Roberts G, Doyle LW ; Victorian Infant Collaborative Group. Underestimation of developmental delay by the new Bayley-III scale. Arch Pediatr Adolesc Med 2010; 164 (4) 352-356
  CrossrefPubMedGoogle Scholar
• 79 Spencer-Smith MM, Spittle AJ, Lee KJ, Doyle LW, Anderson PJ. Bayley-III cognitive and language scales in preterm children. Pediatrics 2015; 135 (5) e1258-e1265
  CrossrefPubMedGoogle Scholar
• 80 Manley BJ, Roberts RS, Doyle LW , et al; Caffeine for Apnea of Prematurity (CAP) Trial Investigators; Caffeine for Apnea of Prematurity CAP Trial Investigators. Social variables predict gains in cognitive scores across the preschool years in children with birth weights 500 to 1250 grams. J Pediatr 2015; 166 (4) 870-876.e1-2
  CrossrefPubMedGoogle Scholar
• 81 Marlow N, Wolke D, Bracewell MA, Samara M ; EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005; 352 (1) 9-19
  CrossrefPubMedGoogle Scholar
• 82 Serenius F, Källén K, Blennow M , et al; EXPRESS Group. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden. JAMA 2013; 309 (17) 1810-1820
  CrossrefPubMedGoogle Scholar
• 83 Beaino G, Khoshnood B, Kaminski M , et al; EPIPAGE Study Group. Predictors of cerebral palsy in very preterm infants: the EPIPAGE prospective population-based cohort study. Dev Med Child Neurol 2010; 52 (6) e119-e125
  CrossrefPubMedGoogle Scholar
• 84 Duncan AF, Bann C, Boatman C , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Do currently recommended Bayley-III cutoffs overestimate motor impairment in infants born <27 weeks gestation?. J Perinatol 2015; 35 (7) 516-521
  CrossrefPubMedGoogle Scholar
• 85 Poole KL, Schmidt LA, Missiuna C, Saigal S, Boyle MH, Van Lieshout RJ. Motor coordination difficulties in extremely low birth weight survivors across four decades. J Dev Behav Pediatr 2015; 36 (7) 521-528
  PubMedGoogle Scholar
• 86 Payne AH, Hintz SR, Hibbs AM , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage. JAMA Pediatr 2013; 167 (5) 451-459
  CrossrefPubMedGoogle Scholar
• 87 Bolisetty S, Dhawan A, Abdel-Latif M, Bajuk B, Stack J, Lui K ; New South Wales and Australian Capital Territory Neonatal Intensive Care Units' Data Collection. Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants. Pediatrics 2014; 133 (1) 55-62
  CrossrefPubMedGoogle Scholar
• 88 Hintz SR, Barnes PD, Bulas D , et al; SUPPORT Study Group of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neuroimaging and neurodevelopmental outcome in extremely preterm infants. Pediatrics 2015; 135 (1) e32-e42
  CrossrefPubMedGoogle Scholar
• 89 Woodward LJ, Anderson PJ, Austin NC, Howard K, Inder TE. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med 2006; 355 (7) 685-694
  CrossrefPubMedGoogle Scholar
• 90 Graham M, Levene MI, Trounce JQ, Rutter N. Prediction of cerebral palsy in very low birthweight infants: prospective ultrasound study. Lancet 1987; 2 (8559) 593-596
  PubMedGoogle Scholar
• 91 Adams-Chapman I, Hansen NI, Stoll BJ, Higgins R ; NICHD Research Network. Neurodevelopmental outcome of extremely low birth weight infants with posthemorrhagic hydrocephalus requiring shunt insertion. Pediatrics 2008; 121 (5) e1167-e1177
  Google Scholar
• 92 Saigal S. Quality of life of former premature infants during adolescence and beyond. Early Hum Dev 2013; 89 (4) 209-213
  CrossrefPubMedGoogle Scholar
• 93 Zwicker JG, Harris SR. Quality of life of formerly preterm and very low birth weight infants from preschool age to adulthood: a systematic review. Pediatrics 2008; 121 (2) e366-e376
  CrossrefPubMedGoogle Scholar
• 94 Kim UO, Basir MA. Informing and educating parents about the risks and outcomes of prematurity. Clin Perinatol 2014; 41 (4) 979-991
  CrossrefPubMedGoogle Scholar
• 95 Guillén Ú, Suh S, Munson D , et al. Development and pretesting of a decision-aid to use when counseling parents facing imminent extreme premature delivery. J Pediatr 2012; 160 (3) 382-387
  CrossrefPubMedGoogle Scholar